The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000449336
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
5/03/2026
Date registered
Help: Date registered
10/04/2026
Date last updated
Help: Date last updated
20/11/2026
Date data sharing statement initially provided
Help: Data sharing statement date
10/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
HEARTBeats: a pilot study of noise-cancelling headphones playing therapeutic suggestions and pleasant music during open heart surgery to improve post-operative pain, anxiety and delirium.
Scientific title
HEARTBeats: recovery after adult cardiac surgery with therapeutic suggestions, pleasant music and noise-cancellation in patients scheduled for cardiac surgery performed via median sternotomy
Additional trial identifiers [1] 316704 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Cardiovascular disease requiring cardiac surgery 340961 0
Coronary Artery Disease 340978 0
Valvular Heart Disease 340979 0
Condition category
Condition code
Cardiovascular 337108 337108 0 0
Coronary heart disease
Cardiovascular 337109 337109 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants will be randomised to either standard perioperative care or standard care plus the study intervention.

The intervention consists of the application of active noise-cancelling over-ear headphones after induction of general anaesthesia for adult cardiac surgery. The headphones will deliver an audio program comprising relaxing music and recorded therapeutic suggestions. The audio program will play continuously during surgery and remain in place postoperatively in the intensive care unit until tracheal extubation. Monitoring adherence to the intervention will occur by direct observation by the clinician caring for the patient (e.g. the anaesthetist during the operation, the ICU nurse during the ICU admission) and sporadic checks by study investigators.

The therapeutic suggestions are delivered via a pre-recorded script developed by an anaesthetist with training in hypnosis and adapted from previously published perioperative suggestion protocols. The audio program includes relaxing music created with input from music therapists and alternates between music, therapeutic suggestions, and brief silent intervals. The intervention is anticipated to last 6-12 hours (depending on how soon the patient is extubated after surgery). An example of therapeutic suggestions include: "The highest priority is your safety and well-being is and the anaesthetist and the health
care professionals are there to ensure your safety and well-being.
They will be by your side at any point in time until you fully recovered from the surgery.
They will provide the best care for you."

Participants in the control group will receive standard perioperative anaesthesia and analgesia without headphones or audio intervention.

Reference: BMJ 2020;371:m4284
Example of therapeutic suggestions Appendix 10.1
Intervention code [1] 333387 0
Treatment: Other
Description of the comparator or control
Participants randomised to the control group will receive standard perioperative care for adult cardiac surgery without the study intervention.

Standard care includes routine general anaesthesia, intraoperative analgesia, and postoperative pain management according to institutional protocols. Intraoperative analgesia typically includes opioid-based induction and maintenance with adjunctive agents as required, followed by protocolised postoperative pain management in the intensive care unit and surgical ward after sternotomy.

Participants in the control group will not receive noise-cancelling headphones or audio intervention during surgery or postoperative care.
Control group
Active

Outcomes
Primary outcome [1] 344625 0
Recruitment feasibility (proportion of eligible patients who consent to participate)
Timepoint [1] 344625 0
From commencement of recruitment until completion of pilot recruitment (40 participants)
Primary outcome [2] 344626 0
Intervention delivery feasibility (proportion of participants receiving the intervention for greater than or equal to 70% of the intended delivery period from induction of anaesthesia until tracheal extubation)
Timepoint [2] 344626 0
From induction of anaesthesia until extubation during the index surgical admission
Primary outcome [3] 344627 0
Completeness of study outcome data (proportion of participants with complete outcome data)
Timepoint [3] 344627 0
Final timepoint for data collection is 30 days post-operative.
Secondary outcome [1] 458680 0
Quality of recovery following cardiac surgery
Timepoint [1] 458680 0
Postoperative day 2 and postoperative day 4 and postoperative day 30
Secondary outcome [2] 458681 0
Postoperative opioid consumption
Timepoint [2] 458681 0
24 hours after surgery
Secondary outcome [3] 458682 0
Postoperative pain intensity
Timepoint [3] 458682 0
Highest rated score on Postoperative Day 2 and Postoperative Day 4
Secondary outcome [4] 458683 0
Postoperative delirium
Timepoint [4] 458683 0
Daily during ICU stay until ICU discharge
Secondary outcome [5] 458684 0
Acceptability of the intervention to participants and treating clinicians
Timepoint [5] 458684 0
Prior to hospital discharge

Eligibility
Key inclusion criteria
Adults aged 18 years or older, scheduled for elective or urgent (non-emergency) cardiac surgery performed via median sternotomy (e.g., coronary artery bypass graft (CABG), valve surgery, combined procedures).
Planned postoperative management in the intensive care unit (ICU) with mechanical ventilation and extubation expected in ICU (to allow delivery of the intervention from induction until extubation).
Able to understand study information and provide written informed consent.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Age less than 18 years.
Cardiac surgery performed without a median sternotomy incision (e.g. minimally invasive or thoracotomy approaches).
Planned rapid-extubation or fast-track cardiac anaesthesia pathway.
Emergency cardiac surgery.
Known hearing impairment preventing perception of the audio intervention
Unable to provide informed consent.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 29240 0
Victorian Heart Hospital - Clayton
Recruitment postcode(s) [1] 45548 0
3168 - Clayton

Funding & Sponsors
Funding source category [1] 321309 0
Hospital
Name [1] 321309 0
Victorian Heart Hospital
Country [1] 321309 0
Australia
Funding source category [2] 323507 0
Charities/Societies/Foundations
Name [2] 323507 0
Australian and New Zealand College of Anaesthetists
Country [2] 323507 0
Australia
Primary sponsor type
Government body
Name
Monash Health
Address
Country
Australia
Secondary sponsor category [1] 324040 0
None
Name [1] 324040 0
Address [1] 324040 0
Country [1] 324040 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319841 0
Monash Health Human Research Ethics Committee A
Ethics committee address [1] 319841 0
Ethics committee country [1] 319841 0
Australia
Date submitted for ethics approval [1] 319841 0
18/12/2025
Approval date [1] 319841 0
22/04/2026
Ethics approval number [1] 319841 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148582 0
Dr Erin McCabe
Address 148582 0
Victorian Heart Hospital, Level 5, 631 Blackburn Road, Clayton VIC 3168
Country 148582 0
Australia
Phone 148582 0
+61 375111656
Fax 148582 0
Email 148582 0
Contact person for public queries
Name 148583 0
Erin McCabe
Address 148583 0
Victorian Heart Hospital, Level 5, 631 Blackburn Road, Clayton VIC 3168
Country 148583 0
Australia
Phone 148583 0
+61 375111656
Fax 148583 0
Email 148583 0
Contact person for scientific queries
Name 148584 0
Erin McCabe
Address 148584 0
Victorian Heart Hospital (Monash Health),Level 5, 631 Blackburn Road, Clayton VIC 3168
Country 148584 0
Australia
Phone 148584 0
+61 375111656
Fax 148584 0
Email 148584 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.